The CEO said the acquisition from Smarsh, which closed in January, was made by Azra's owner, Invenero Health LLC.
Azra AI's uses AI to identify incidental lung nodules in medical reports for liver, kidney and adrenal, pancreatic, and ovarian...
Clinical Intelligence Platform includes liver, kidney and adrenal, thyroid, pancreas and ovarian cancers, aneurysms.
Learn how Azra AI's technology is positively impacting health outcomes for cancer patients and reducing the work load burden. AI...
Healthcare executive Brook Blackmore has joined the leadership team of Azra AI, the leading AI SaaS company helping to accelerate...
